Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City
ONCOLOGY · 22.07.2026 · 40 (6)
DOI: 10.46883/2026.25921234 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift ONCOLOGY, online erschienen am 22.07.2026. Verfasst von José Luis Rodríguez-Olivares und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Prostatic Neoplasms, DNA Mismatch Repair. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Metastatic prostate cancer treatment has evolved in the past few decades, finding targeted therapy in the homologous recombination repair (HRR) pathway and mismatch repair (MMR) deficiency. METHODS: This cross-sectional study evaluated men with metastatic prostate cancer treated at a referral center in Mexico City, Mexico. Next-generation sequencing was used. MMR status was evaluated via immunohistochemistry. This study aimed to characterize the genetic landscape in a cohort of Mexican patients. RESULTS: Among 186 patients who underwent somatic testing, 101 also had germline testing. Age at diagnosis was 68 years (range, 41-90), 52.7% had de novo metastatic disease, and 35.5% had metastatic castration-resistant disease. A total of 52 somatic pathogenic variants (PVs) in HRR genes were identified in 45 patients (24.2%); ATM, PALB2, CHEK2, and BRCA2 were the most common. Among 101 individuals with germline genetic testing, 12 (11.8%) carried germline PVs, most frequently in ATM and CHEK2. A higher proportion of germline PV carriers was observed in patients with HRR-positive tumors (28.6% vs 4.1%; P = .001). MMR deficiency was found in 3 out of 140 patients (2.1%). CONCLUSION: Although the overall frequency of PVs is consistent with that reported in other populations, the spectrum of PVs may reflect a distinct molecular profile among Mexican patients with metastatic prostate cancer. KEYWORDS: Prostatic neoplasms/genetics, DNA repair/genetics, germline mutation, genetic testing/methods, health care disparities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Rodríguez-Olivares, J. L., Mauricio Mora Pineda Md, Beas-Lozano, E., Alec Seidman-Sorsby Md, Remolina-Bonilla, Y. A., Armando Gamboa-Domínguez Md, Jeffrey Weitzel Md Facmg, Pedro Barata Md MSc, Yanin Chavarri-Guerra Md MSc Fasco, & Bourlon, M. T. (2026). Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City. ONCOLOGY, 40(6). https://doi.org/10.46883/2026.25921234
Vancouver
Rodríguez-Olivares JL, Mauricio Mora Pineda Md, Beas-Lozano E, Alec Seidman-Sorsby Md, Remolina-Bonilla YA, Armando Gamboa-Domínguez Md, et al. Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City. ONCOLOGY. 2026;40(6). doi:10.46883/2026.25921234
BibTeX
@article{RodrguezOlivares2026,
author = {Rodríguez-Olivares, José Luis and Mauricio Mora Pineda Md and Beas-Lozano, Evelyn and Alec Seidman-Sorsby Md and Remolina-Bonilla, Yuly A and Armando Gamboa-Domínguez Md and Jeffrey Weitzel Md Facmg and Pedro Barata Md MSc and Yanin Chavarri-Guerra Md MSc Fasco and Bourlon, María T},
title = {Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City},
journal = {ONCOLOGY},
year = {2026},
volume = {40},
number = {6},
doi = {10.46883/2026.25921234}
}
EUVIMED